Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
42.62
1.07 (2.58%)
At close: Aug 15, 2025, 3:59 PM
43.44
1.92%
After-hours: Aug 15, 2025, 05:03 PM EDT

Kymera Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
120.26M 109.97M 68.39M 47.98M
Short-Term Investments
368.49M 264.92M 338.77M 394.44M
Long-Term Investments
362.16M 61.43M 152.33M 125.19M
Other Long-Term Assets
7.74M 7.93M -122.02M -98.77M
Receivables
947K 18.76M 2.54M 135K
Inventory
n/a n/a -12.25M -8.99M
Other Current Assets
20.58M 11.67M 9.71M n/a
Total Current Assets
510.27M 405.32M 559.49M 567.61M
Property-Plant & Equipment
97.86M 101.08M 13.33M 11.88M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
467.77M 170.44M 43.64M 38.3M
Total Assets
978.03M 575.76M 603.13M 605.9M
Account Payables
5.99M 7.08M 4.33M 4M
Deferred Revenue
13.58M 37.88M 63.26M 101.03M
Short-Term Debt
13.11M n/a 3.94M 3.6M
Other Current Liabilities
21.98M 23.16M 15.71M -3.37M
Total Current Liabilities
67.77M 85.69M 63.26M 101.03M
Long-Term Debt
n/a n/a 13.39M 14.36M
Other Long-Term Liabilities
n/a n/a -13.14M -14.3M
Total Long-Term Liabilities
74.65M 95.1M 49.72M 45.23M
Total Liabilities
142.42M 180.79M 112.98M 146.27M
Total Debt
87.76M 84.67M 17.34M 17.96M
Common Stock
7K 6K 6K 5K
Retained Earnings
-754.61M -530.75M -383.79M -228.98M
Comprehensive Income
-1.49M -552K -4.95M -660K
Shareholders Equity
835.62M 394.97M 490.15M 459.64M
Total Investments
730.65M 326.35M 491.1M 519.63M